NEWS

Our Latest News

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

ARCHIMED’s MED II fund earns a 6x return on EUROLyser, its first exit

 May

 9, 

2022

ARCHIMED sells health ingredients developer Fytexia to Associated British Foods

 February

 2, 

2022

ARCHIMED buys CARSO, a leader in purity testing for pharma and other industries

 December

 16, 

2021

ARCHIMED reaches agreement to sell Bomi Group to UPS

 December

 16, 

2021

ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients

 November

 18, 

2021

ARCHIMED buys Cardioline, Europe’s leader in cardiology-focused telemedicine

 November

 17, 

2021

1 2 3 4 5 6 … 14
368